Article info
PDFArchimedes
Question 2 Should hypertonic saline be used in patients with cystic fibrosis who respond unsatisfactorily to recombinant deoxyribonuclease?
- Correspondence to Shiraz Badurdeen, School of Clinical Medicine, University of Cambridge, Peterhouse, Cambridge CB2 1RD, UK; sb470{at}doctors.org.uk
Citation
Question 2 Should hypertonic saline be used in patients with cystic fibrosis who respond unsatisfactorily to recombinant deoxyribonuclease?
Publication history
- Accepted August 6, 2009
- First published June 15, 2010.
Online issue publication
March 22, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions